Shire acquires 98.8% stake in Jerini - MarketLine Financial Deals

Shire acquires 98.8% stake in Jerini

Shire acquires 98.8% stake in Jerini - MarketLine Financial Deals
Shire acquires 98.8% stake in Jerini
Published Jul 03, 2008
3 pages — Published Jul 03, 2008
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Shire Limited (formerly Shire plc), an UK-based specialty biopharmaceutical company, has acquired 98.8% voting interest in Jerini AG, a Germany-based pharmaceutical company focused on developing peptide-based drugs, for $557.8 million.

  
Source:
Document ID
MA05484_090619
Country
Country
Ticker
SHP=GB
Ticker
JI4=DE
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Shire acquires 98.8% stake in Jerini" Jul 03, 2008. Alacra Store. Dec 11, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Shire-acquires-98-8-stake-in-Jerini-2052-5210>
  
APA:
MarketLine Financial Deals. (2008). Shire acquires 98.8% stake in Jerini Jul 03, 2008. New York, NY: Alacra Store. Retrieved Dec 11, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Shire-acquires-98-8-stake-in-Jerini-2052-5210>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.